New HRS Drug Cuts Need for Renal Replacement Tx After Liver Transplant
(MedPage Today) -- Terlipressin (Terlivaz) reduced the need for renal replacement therapy (RRT) in patients with type 1 hepatorenal syndrome (HRS) who underwent liver transplant, extended follow-up of the phase III CONFIRM trial showed.
In the...
Source: MedPage Today Surgery - Category: Surgery Source Type: news
More News: Liver | Liver Transplant | Surgery | Transplant Surgery | Transplants | Urology & Nephrology